Статус неизвестен
Фаза II
Россия
Naxitamab; GM-CSF; Isotretinoin · Y-mAbs Therapeutics
Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission. An International, Open-Label,Uncontrolled, Single-Arm, Multicenter, Phase 2 Trial